GPT and diabetes mellitus: The BARD score (which includes the following 3 variables: body mass index [BMI], aspartate aminotransferase [AST]/alanine aminotransferase [ALT] ratio, and diabetes) is a noninvasive system that was developed to predict advanced fibrosis in patients with NALFD [15].